This course has expired. View available courses.
Neurology
Initiating a CGRP-targeted therapy – practical aspects of care
Migraine is a neurological condition that affects an estimated 4.9 million Australians. It is associated with significant wellbeing costs for those living with migraine disease as well as a total estimated economic cost in Australia of $35.7 billion in 2018. Despite this substantial impact, migraine remains under-diagnosed and under-treated in Australia. The fourth of this 4-part series revisits the case study of a typical patient […]
DURATION
15 min
PROFESSION
Physician
# OF CREDITS
2
ACCREDITATION
RACGP CPD Program
EXPIRY DATE
2021-12-07
Migraine is a neurological condition that affects an estimated 4.9 million Australians. It is associated with significant wellbeing costs for those living with migraine disease as well as a total estimated economic cost in Australia of $35.7 billion in 2018.
Despite this substantial impact, migraine remains under-diagnosed and under-treated in Australia.
The fourth of this 4-part series revisits the case study of a typical patient presenting with worsening migraines and examines practical aspects of initiating a CGRP-targeted therapy.
Participants must read all 4 issues and then complete the questions on Issue 4 to claim RACGP CPD points.
This program is supported by an independent educational grant provided by Eli Lilly.
Faculty
Dr Bronwyn Jenkins, Neurologist, FRACP, BMed
Dr Christina Sun Edelstein, Neurologist, FRACP, MD
Dr Simon Cowap, General Practitioner
Learning objectives
On completion of this clinical brief, GPs will be able to:
- Define migraine as a neurological disorder and understand its clinical phases
- Recognise the burden of migraine including its significant impact on quality of life
- Demonstrate how the introduction of CGRP inhibitors has changed the treatment paradigm in migraine prevention
- Identify patients who could benefit from timely introduction of preventive therapy, including CGRP inhibitors
- Confidently initiate preventative treatments as an effective strategy in migraine management
- Understand the place of CRGP inhibitors in migraine prevention strategies
- Develop strategies for ensuring optimal outcomes with preventive therapy including monitoring, counseling patients on administration and adherence, and providing self-care advice
Accreditation
This Active Learning Module has been approved by RACGP CPD Program for 2 CPD points.
Activity no. 226888
Members are able to claim CPD activity points for 2 points through 'Quick log' on their RACGP CPD Dashboard.